⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 14, 2024Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition

The value of MR perfusion and diffusion combined with tumor marker analysis in differentiating benign and malignant ovarian tumors

Jinsong Bai Haitao Zhang S L Wang

View Full Paper

Ask AI

Bookmark

Share

Abstract

The aim of our study was to compare the differential diagnostic efficacy of dynamic contrast enhanced magnetic resonance imaging (DCE-MRI), apparent diffusion coefficient (ADC), serum carbohydrate antigen 125 (CA125), human epididymal secretory protein 4 (HE4) and their combined application in benign and malignant ovarian tumors, and to explore the best method for the diagnosis of ovarian tumors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bai et al. (2024) studied this question.

synapsesocial.com/papers/68e5c52db6db64358755bd99 https://doi.org/10.58530/2023/4273

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The application of MR perfusion and diffusion combined with tumor marker diagnosis for the identification of benign and malignant ovarian tumors2024
2The role of dynamic contrast enhanced MR imaging in the assessment of inconclusive ovarian massesOriginal Research · 2017 · 5 citations
3The Value of dynamic contrast-enhanced MRI in differential diagnosis of solid ovarian tumors with diffusion restriction2024
4Serum CA125 and HE4 levels combined with magnetic resonance imaging (MRI) in the clinical diagnostic value of ovarian neoplasms2024 · 3 citations
5MRI evaluation of pediatric ovarian tumors: morphological features and preliminary assessment of diffusion-weighted imagingCohort Study · 2026